Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study
Rahman, Mohummad A., Brekke, Jorunn, Arnesen, Victoria, Hannisdal, Marianne H., Navarro, Andrea G., Waha, Andreas, Herfindal, Lars, Rygh, Cecilie B., Bratland, Eirik, Brandal, Petter, Haasz, Judit, Oltedal, Leif, Miletic, Hrvoje, Lundervold, Arvid, Lie, Stein A., Goplen, Dorota, Chekenya, Martha
Published in Immunity, Inflammation and Disease (01.09.2020)
Published in Immunity, Inflammation and Disease (01.09.2020)
Get full text
Journal Article
Abstract 2928: Bortezomib sensitizes glioblastoma with unmethylated MGMT promoter to temozolomide-chemotherapy through MGMT depletion and abrogated autophagy flux
Rahman, Mohummad A., Navarro, Andrea G., Brekke, Jorunn, Bindesbøll, Christian, Engelsen, Agnete, Sarowar, Shahin, Bahador, Marzieh, Gjertsen, Bjørn T., Goplen, Dorota, Enger, Per Ø., Selheim, Frode, Simonsen, Anne, Chekenya, Martha
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article